Epicardial adipose tissue (EAT) volume and fatty acid composition (FAC) have significant roles in EAT-mediated coronary vascular inflammation. Using MRI of EAT volume and FAC, we tested the hypothesis that eplerenone reduces EAT volume and alters its FAC in a mouse model of obesity. We show that eplerenone significantly reduces EAT volume after 30 weeks on a high-fat high-sucrose diet compared to untreated mice. In addition, the EAT FAC is shifted from saturated fatty acid dominant in untreated mice to poly-unsaturated fatty acid dominant in eplerenone-treated mice. The results suggest that eplerenone has an anti-inflammatory role in obesity-related EAT.
This abstract and the presentation materials are available to members only; a login is required.